Advertisement

Topics

Prolacta Bioscience Company Profile

23:20 EST 10th December 2018 | BioPortfolio

Prolacta Bioscience, headquartered in Monrovia, Calif., provides pharmaceutical grade specialty formulations of human milk for use in the nutrition of low birth weight (LBW) and very low birth weight (VLBW) babies. Prolacta sells its products directly to the neonatal intensive care units (NICU) of hospitals, specializing on the nutritional needs of underweight and critically ill babies, focused on the first 30 days of life. Prolacta Bioscience has developed improved methods for testing, formulating and processing of human milk. Prolacta's dedication to quality assurance in milk testing ensures that hospitals and physicians can trust the Prolacta's human milk formulations provided to premature babies meet the highest quality and safety standards. Prolacta's large-capacity human milk processing capabilities ensures a steady supply of high-quality human milk formulations targeted specifically to meet the requirements of very low birthweight premature infants. Prolacta is committed to ensuring that all babies receive the benefits of human milk. To achieve this, Prolacta is helping communities establish milk banks to address the critical shortage of human milk for sick babies. PROLACTA IS ALSO COMMITTED TO SUPPORTING RESEARCH IN THE AREAS OF HUMAN MILK AND PREMATURE INFANT NUTRITION IN ORDER TO ASSIST HEALTH CARE PROFESSIONALS IN PROVIDING THE BEST POSSIBLE CARE FOR THESE VULNERABLE BABIES

Location

605 E Huntington Dr.
Monrovia
California
91016
United States of America

Contact

Phone: 1-888-PROLACTA
Fax: 1-626-599-9269
Email: info@prolacta.com


News Articles [335 Associated News Articles listed on BioPortfolio]

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment PR Newswire London, August 5 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATIO...

Aytu BioScience, Inc.: Aytu BioScience Announces Pricing of $13.2 Million Underwritten Public Offering

ENGLEWOOD, CO / ACCESSWIRE / October 5, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant ...

Aytu BioScience, Inc.: Aytu BioScience Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

ENGLEWOOD, CO / ACCESSWIRE / October 10, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant...

Twist Bioscience Files for $86.3M IPO

Today, Twist Bioscience filed an S-1 with the U.S. Securities and Exchange Commission (SEC), announcing its intent to undergo an initial public offering. The filing shows that Twist intends to raise $...

Aytu BioScience, Inc.: Aytu BioScience to Present at 11th Annual LD Micro Main Event Investor Conference on December 5, 2018

ENGLEWOOD, CO / ACCESSWIRE / November 27, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significan...

Aytu BioScience, Inc.: Aytu BioScience Reports 55% Sequential Revenue Growth in Q1 FY19; Adds Tuzistra(R) XR to Portfolio

Company Posts Highest Ever Quarterly Revenue ENGLEWOOD, CO / ACCESSWIRE / November 7, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercializa...

Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to ...

Cyclenium Pharma Inc.Helmut Thomas, Ph.D., DABT, +1-819-571-4296President, CEO & CSOhthomas@cyclenium.comorHaplogen Bioscience GmbHGeorg Casari, Ph.D., +43-1-9165522Chief Exec...

Arix Bioscience Plc - Director/PDMR Shareholding

Arix Bioscience Plc - Director/PDMR Shareholding PR Newswire London, June 11 ARIX BIOSCIENCE PLC Director/PDMR Shareholding Arix Bioscience plc today announces the annual award of nil cost options...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

O24 [Revive Bioscience, Inc.]

Abraxane [Abraxis BioScience, LLC]

These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE ABRAXANE® for Injectable Suspension (paclitaxel protei...

Idkit hp one [Exalenz Bioscience Ltd.]

Package Insert IDkit:Hp™ for the Exalenz BreathID® System BREATH TEST FOR DETECTION of H. pylori

PubMed Articles [63 Associated PubMed Articles listed on BioPortfolio]

Improving Undergraduate Life Science Education for the Biosciences Workforce: Overcoming the Disconnect between Educators and Industry.

The BioHealth Capital Region (Maryland, Virginia, and Washington, DC; BHCR) is flush with colleges and universities training students in science, technology, engineering, and mathematics disciplines a...

Youtube for millennial nursing students; using internet technology to support student engagement with bioscience.

Undergraduate nursing programs typically include students with limited 'on-campus' time who need learning resources that are flexible, technologically appropriate, remotely-accessible (mobile smart de...

Association between three genetic variants in kallikrein 3 and prostate cancer risk.

Epidemiological studies have assessed the association between kallikrein 3 (KLK3) polymorphisms and prostate cancer (PCa) susceptibility. However, published data on this association are somewhat incon...

Heat shock protein 70 protects mouse against post-infection irritable bowel syndrome via up-regulating intestinal γδ T cell's Th17 response.

This study investigated the role of HSP70 in modulating intestinal γδ T cells' Th17 response in -induced PI-IBS mice model.

Resveratrol enhances matrix biosynthesis of nucleus pulposus cells through activating autophagy via the PI3K/Akt pathway under oxidative damage.

The decrease in nucleus pulposus (NP) matrix production is a classic  feature during disc degeneration. Resveratrol (RSV) is reported to play protective effects under many pathological factors.

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Metabolic syndrome increases the risk for development of heart disease. Another condition associated with metabolic syndrome is fatty liver disease which is also referred to as nonalcoholi...

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

This pilot study will try to minimize the pain during exposure to a new red light source (RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without compromising it...

Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects

Photomodulation is a process which manipulates or regulates cell activity using light sources without thermal effect. Different studies have investigated the use of non-thermal low dose li...

Companies [313 Associated Companies listed on BioPortfolio]

Prolacta Bioscience, Inc.

Prolacta Bioscience, Inc. (www.prolacta.com) is a life science company dedicated to improving quality of life by Advancing the Science of Human MilkTM. Prolacta creates specialty ...

Prolacta Bioscience

Prolacta Bioscience, headquartered in Monrovia, Calif., provides pharmaceutical grade specialty formulations of human milk for use in the nutrition of low birth weight (LBW) and very low birth weight ...

The Idaho Bioscience Association

The Idaho Bioscience Association is a non-profit organization that brings together corporate, academic and political leaders to educate the public and to promote bioscience activities in the state. B...

Sprint Bioscience

Sprint Bioscience AB (publ) is part of the new Swedish pharmaceutical industry. The company has the goal to develop drug candidates for the global pharmaceutical market within the...

Bioscience Bridge, LLC

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we...

More Information about "Prolacta Bioscience" on BioPortfolio

We have published hundreds of Prolacta Bioscience news stories on BioPortfolio along with dozens of Prolacta Bioscience Clinical Trials and PubMed Articles about Prolacta Bioscience for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prolacta Bioscience Companies in our database. You can also find out about relevant Prolacta Bioscience Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...


Corporate Database Quicklinks



Searches Linking to this Company Record